NAFRONYL for Peripheral arterial occlusive disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where NAFRONYL was used for Peripheral arterial occlusive disease.
Most Reported Side Effects for NAFRONYL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 22 | 19.0% | 3 | 20 |
| Hepatic cytolysis | 19 | 16.4% | 19 | 13 |
| Toxicity to various agents | 19 | 16.4% | 19 | 13 |
| Acute pulmonary oedema | 18 | 15.5% | 18 | 12 |
| Cardiac disorder | 17 | 14.7% | 17 | 11 |
| Lactic acidosis | 14 | 12.1% | 2 | 9 |
| Synovitis | 14 | 12.1% | 14 | 13 |
| Cerebral haemorrhage | 13 | 11.2% | 0 | 0 |
| Anaemia | 12 | 10.3% | 0 | 0 |
| Coronary artery stenosis | 12 | 10.3% | 12 | 11 |
| Encephalopathy | 12 | 10.3% | 12 | 7 |
| Renal cell carcinoma | 12 | 10.3% | 0 | 0 |
| Respiratory depression | 12 | 10.3% | 12 | 7 |
| Drug abuse | 11 | 9.5% | 11 | 10 |
| Hyperkalaemia | 11 | 9.5% | 1 | 11 |
Other Indications for NAFRONYL
Product used for unknown indication (63)
Intermittent claudication (13)
Thromboangiitis obliterans (12)
Peripheral vascular disorder (8)
Other Drugs Used for Peripheral arterial occlusive disease
RIVAROXABAN (761)
CLOPIDOGREL BISULFATE (700)
ASPIRIN (657)
CILOSTAZOL (94)
TICAGRELOR (89)
ASPIRIN DL-LYSINE (72)
EVOLOCUMAB (58)
APIXABAN (55)
ATORVASTATIN (55)
UNSPECIFIED INGREDIENT (50)